An Open Label, Expanded Access Protocol With SAGE-547 for Super-Refractory Status Epilepticus
Status:
No longer available
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This is an open-label, expanded access protocol, designed to offer treatment with SAGE-547 to
subjects in SRSE, and to evaluate the efficacy and safety of SAGE-547 administered as a
continuous intravenous infusion to these subjects